Anti-IL13(lebrikizumab biosimilar) mAb

Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: Anti-IL13(lebrikizumab biosimilar，IgG4) mAb

Storage & Shipping: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Formulation & Reconstitution: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.

Target: IL13

Uniprot ID: P35225

Usage: Research use only

Recommended Dilutions: N/A

Common Name: DRM 06DRM-06DRM06DRM 6DRM-6DRM6LY 3650150LY-3650150LY3650150MILR1444AMILR-1444AMILR 1444ARG 3637ARG-3637ARG3637RO 5490255RO-5490255RO5490255TNX 650TNX-650TXN650

Guarantee: 12 months from date of dispatch

• Artikelnummer: DMABME100548-50
• Hersteller: DIMA Biotechnology
• Hersteller Artikelnummer: BME100548-50
• Verpackungseinheit: 50 µg
• Mengeneinheit: STK
• Reaktivität: Human
• Methode: Flow Cytometry
• Isotyp: IgG4
• Konjugat: Unconjugated